The objective of the Master of Business and Science (MBS) degree with a concentration in Biotechnology and Genomics is to educate students in the essential skills for managing technical development and commercial applications in industries that apply and make use of the molecular biological sciences, including biotechnology, genomics and proteomics, biochemistry, cell biology, systems biology and nanobiotechnology. Biotechnology is a rapidly moving transformative technology that has applications in industries as diverse as healthcare, pharmaceutical development, agriculture, alternative energy, environmental monitoring and restoration, and nanotechnology. In particular, biotechnology is now the predominant technology underpinning the development of new pharmaceuticals and medical diagnostics and treatments. Genomics is the study of whole genomes (the entire genetic complement of an organism) and is focused on the structure and behavior of all the genes in an organism or ecosystem. Genomics is an application of biotechnology that has developed in the last 10 years and places a particular emphasis on understanding how very large numbers of genes interact with each other and with their environment. Genomics has been made possible by new and rapidly evolving developments in structural and analytical methods (e.g., ultra-high throughput DNA sequencing) along with the development of the computational approaches needed to handle large datasets. Genomics is rapidly finding applications in industry (e.g., in developing personalized medicine, finding new drug targets or searching for novel industrial enzymes in exotic microflora).